Generic Reviews Getting NDA-Style Communication Enhancements
Executive Summary
Despite its unprecedented workload, FDA's Office of Generic Drugs is getting more chatty at work: the office is changing its policy to allow for phone communications with applicants
You may also be interested in...
ANDA Review Improvements Continue As FDA Eyes Generic User Fee Resources
FDA's review backlog for ANDAs requires a "significant" improvement in resources, Office of Generic Drugs Director Gary Buehler said
ANDA Review Improvements Continue As FDA Eyes Generic User Fee Resources
FDA's review backlog for ANDAs requires a "significant" improvement in resources, Office of Generic Drugs Director Gary Buehler said
“First Generics” Will Get Expedited ANDA Reviews Under New FDA Policy
FDA's "First Generics" policy sets a priority review goal of six months for ANDAs for which there is no marketed generic equivalent